nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0444	0.0763	CcSEcCtD
Misoprostol—PTGER4—renal system—nephrolithiasis	0.0331	0.219	CbGeAlD
Misoprostol—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0321	0.0552	CcSEcCtD
Misoprostol—PTGER4—kidney—nephrolithiasis	0.032	0.211	CbGeAlD
Misoprostol—PTGER4—cortex of kidney—nephrolithiasis	0.0312	0.206	CbGeAlD
Misoprostol—PTGER3—renal system—nephrolithiasis	0.028	0.185	CbGeAlD
Misoprostol—PTGER3—kidney—nephrolithiasis	0.0271	0.179	CbGeAlD
Misoprostol—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0358	CcSEcCtD
Misoprostol—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0323	CcSEcCtD
Misoprostol—Gout—Hydrochlorothiazide—nephrolithiasis	0.0181	0.0311	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0164	0.0613	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—PTH—nephrolithiasis	0.0161	0.0603	CbGpPWpGaD
Misoprostol—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0262	CcSEcCtD
Misoprostol—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.014	0.024	CcSEcCtD
Misoprostol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0235	CcSEcCtD
Misoprostol—PTGER2—G alpha (s) signalling events—PTH—nephrolithiasis	0.0132	0.0495	CbGpPWpGaD
Misoprostol—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0221	CcSEcCtD
Misoprostol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0218	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0211	CcSEcCtD
Misoprostol—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0111	0.019	CcSEcCtD
Misoprostol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.011	0.019	CcSEcCtD
Misoprostol—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0182	CcSEcCtD
Misoprostol—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0099	0.017	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00984	0.0169	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00978	0.0367	CbGpPWpGaD
Misoprostol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00975	0.0168	CcSEcCtD
Misoprostol—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0163	CcSEcCtD
Misoprostol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00931	0.016	CcSEcCtD
Misoprostol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0159	CcSEcCtD
Misoprostol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0159	CcSEcCtD
Misoprostol—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0158	CcSEcCtD
Misoprostol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0158	CcSEcCtD
Misoprostol—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.009	0.0155	CcSEcCtD
Misoprostol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00891	0.0153	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00838	0.0314	CbGpPWpGaD
Misoprostol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00817	0.014	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00803	0.0301	CbGpPWpGaD
Misoprostol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0136	CcSEcCtD
Misoprostol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00757	0.013	CcSEcCtD
Misoprostol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00749	0.0129	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00741	0.0278	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—RGS14—nephrolithiasis	0.00739	0.0277	CbGpPWpGaD
Misoprostol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00727	0.0125	CcSEcCtD
Misoprostol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0123	CcSEcCtD
Misoprostol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00709	0.0122	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00688	0.0258	CbGpPWpGaD
Misoprostol—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00682	0.0117	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—RGS14—nephrolithiasis	0.00671	0.0251	CbGpPWpGaD
Misoprostol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00662	0.0114	CcSEcCtD
Misoprostol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0111	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CHRM3—nephrolithiasis	0.00638	0.0239	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00635	0.0238	CbGpPWpGaD
Misoprostol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0108	CcSEcCtD
Misoprostol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0108	CcSEcCtD
Misoprostol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0108	CcSEcCtD
Misoprostol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00626	0.0108	CcSEcCtD
Misoprostol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00607	0.0104	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00607	0.0227	CbGpPWpGaD
Misoprostol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00602	0.0104	CcSEcCtD
Misoprostol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00602	0.0104	CcSEcCtD
Misoprostol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00593	0.0102	CcSEcCtD
Misoprostol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0101	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—PTH—nephrolithiasis	0.00584	0.0219	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00582	0.01	CcSEcCtD
Misoprostol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00967	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—RGS14—nephrolithiasis	0.0056	0.021	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—RGS14—nephrolithiasis	0.00551	0.0206	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00943	CcSEcCtD
Misoprostol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00923	CcSEcCtD
Misoprostol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00535	0.0092	CcSEcCtD
Misoprostol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00911	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00524	0.0196	CbGpPWpGaD
Misoprostol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00892	CcSEcCtD
Misoprostol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00885	CcSEcCtD
Misoprostol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00885	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—RGS14—nephrolithiasis	0.00508	0.0191	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DGKH—nephrolithiasis	0.00499	0.0187	CbGpPWpGaD
Misoprostol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00853	CcSEcCtD
Misoprostol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00846	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00484	0.0181	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—PTH—nephrolithiasis	0.00479	0.018	CbGpPWpGaD
Misoprostol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00818	CcSEcCtD
Misoprostol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00818	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—ADCY10—nephrolithiasis	0.00466	0.0175	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DGKH—nephrolithiasis	0.00453	0.017	CbGpPWpGaD
Misoprostol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00763	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—PTH—nephrolithiasis	0.00442	0.0166	CbGpPWpGaD
Misoprostol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00743	CcSEcCtD
Misoprostol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00708	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—DGKH—nephrolithiasis	0.0041	0.0154	CbGpPWpGaD
Misoprostol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00684	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—RGS14—nephrolithiasis	0.00396	0.0149	CbGpPWpGaD
Misoprostol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00658	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—ADCY10—nephrolithiasis	0.00383	0.0143	CbGpPWpGaD
Misoprostol—Rash—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00653	CcSEcCtD
Misoprostol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00652	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00378	0.0142	CbGpPWpGaD
Misoprostol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00648	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—DGKH—nephrolithiasis	0.00372	0.0139	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00361	0.0135	CbGpPWpGaD
Misoprostol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00615	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ADCY10—nephrolithiasis	0.00353	0.0132	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DGKH—nephrolithiasis	0.00343	0.0129	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PTH—nephrolithiasis	0.0033	0.0124	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00328	0.0123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RGS14—nephrolithiasis	0.00325	0.0122	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RGS14—nephrolithiasis	0.003	0.0113	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PTH—nephrolithiasis	0.003	0.0112	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00296	0.0111	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00273	0.0102	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PTH—nephrolithiasis	0.00271	0.0102	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00269	0.0101	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00268	0.01	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DGKH—nephrolithiasis	0.00268	0.01	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PTH—nephrolithiasis	0.0025	0.00937	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00248	0.0093	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PTH—nephrolithiasis	0.00246	0.00922	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PTH—nephrolithiasis	0.00227	0.00851	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0022	0.00824	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DGKH—nephrolithiasis	0.0022	0.00824	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00203	0.0076	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DGKH—nephrolithiasis	0.00203	0.0076	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CHRM3—nephrolithiasis	0.00193	0.00725	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTH—nephrolithiasis	0.00177	0.00663	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CHRM3—nephrolithiasis	0.00159	0.00596	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CHRM3—nephrolithiasis	0.00147	0.0055	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTH—nephrolithiasis	0.00145	0.00545	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTH—nephrolithiasis	0.00134	0.00503	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SPP1—nephrolithiasis	0.000888	0.00333	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SPP1—nephrolithiasis	0.00073	0.00273	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SPP1—nephrolithiasis	0.000673	0.00252	CbGpPWpGaD
